Unable to connect, retrying...
Online collaborative whiteboard. Powerful, engaging with timer, emoji's, commenting and voting.
Search for RSS feeds

Immunotherapy proven to slow T1D progression in people newly diagnosed now being tested for prevention

Amber Van Den Heuvel received low-dose anti-thymocyte globulin (ATG) in 2015 as a participant in a TrialNet clinical study for people newly diagnosed with type 1 diabetes (T1D). Five years later,...

https://www.trialnet.org/events-news/blog/immunotherapy-proven-slow-t1d-progression-people-newly-diagnosed-now-being-tested?fbclid=IwAR3_Hx1nbhbqzRduhuQln-_jeCE7naDfNRI8dk0yt4DU3nn9X3gbJIBXfFw